FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "OSRX, Inc.(117108300)" | 83826-9030 | 83826-9030-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| OSRX, Inc. | 83826-9030 | 83826-9030-5 | Bimatoprost, Brimonidine Tartrate, Dorzolamide | Bimatoprost 0.01%, Brimonidine Tartrate 0.1%, Dorzolamide 2% | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| "OSRX, Inc.(117108300)" | 83826-9030 | 83826-9030-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| OSRX, Inc. | 83826-9030 | 83826-9030-5 | Bimatoprost, Brimonidine Tartrate, Dorzolamide | Bimatoprost 0.01%, Brimonidine Tartrate 0.1%, Dorzolamide 2% | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| "OSRX, Inc.(117108300)" | 83826-9030 | 83826-9030-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-1 | valid | 2026-10-06 | ||
| OSRX, Inc. | 83826-9030 | 83826-9030-5 | Bimatoprost, Brimonidine Tartrate, Dorzolamide | Bimatoprost 0.01%, Brimonidine Tartrate 0.1%, Dorzolamide 2% | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| "OSRX, Inc.(117108300)" | 83826-9030 | 83826-9030-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2024-2 | valid | 2026-10-06 | ||
| OSRX, Inc. | 83826-9030 | 83826-9030-5 | Bimatoprost, Brimonidine Tartrate, Dorzolamide | Bimatoprost 0.01%, Brimonidine Tartrate 0.1%, Dorzolamide 2% | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2024-2 | valid | 2026-09-18 |